Business Context and Reporting Period
This Form 6-K filing by Can-Fite Biopharma Ltd. covers the month of January 2017. The report addresses a corporate governance event regarding a Special Meeting of Shareholders.
Financial Metrics
The filing text does not provide a clear value for revenue, profit, cash flow, margins, debt, or liquidity. This document is a procedural notice and does not contain financial statements.
Material Changes
There are no material financial changes reported in this filing. The primary event is the adjournment of a shareholder meeting.
Outlook, Risks, and Management Commentary
On January 12, 2017, the Company convened a Special Meeting of Shareholders. The meeting was adjourned for one week due to a lack of quorum. The meeting is scheduled to be reconvened on Thursday, January 19, 2017, at 4:00 p.m. (Israel time) at the Company's offices in Petach Tikva, Israel.
Key Facts for Investor Verification
- The Special Meeting of Shareholders originally scheduled for January 12, 2017, failed to achieve a quorum.
- The meeting has been rescheduled for January 19, 2017, at the same time and location.
- No financial performance data is included in this specific filing.